
Incorporating MRD into Monitoring After Fixed-Duration CLL Treatment
John N. Allan, MD (Moderator) Associate Professor of Clinical Medicine Division of Hematology and Medical Oncology Weill Cornell Medicine New York, NY [Continued from part 1] CASE SUMMARY History and presentation: A 66-year-old woman presented with …